Skip to contentI
INSMED Inc
I
INSMINSMED Inc Source filing unavailable
Q3 2014 · —
Revenue—
Net Income-$23.99M-$23.99MN/M vs Q3 2013 EPS Diluted-$0.54-$0.54N/M vs Q3 2013 Operating Income-$23,404,000N/M Operating Cash Flowderived-$20,905,000N/M Free Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
-$23,824,000
N/M